SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-024297
Filing Date
2015-04-22
Accepted
2015-04-22 16:01:23
Documents
5
Period of Report
2015-06-08
Effectiveness Date
2015-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A v407774_def14a.htm DEF 14A 332555
2 GRAPHIC tpg28.jpg GRAPHIC 1157
3 GRAPHIC tpg28a.jpg GRAPHIC 3287
4 GRAPHIC tpg28b.jpg GRAPHIC 3405
5 GRAPHIC tpg28c.jpg GRAPHIC 4572
  Complete submission text file 0001144204-15-024297.txt   351349
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 15785646
SIC: 2834 Pharmaceutical Preparations